Seelos therapeutics to participate in the benchmark company healthcare conference

New york, may 21, 2021 /prnewswire/ -- seelos therapeutics, inc. (nasdaq: seel), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it will participate in the benchmark company healthcare house call virtual video 1x1 investor conference on wednesday, may 26, 2021. raj mehra, ph.d.
SEEL Ratings Summary
SEEL Quant Ranking